Comera Life Sciences Inc... (CMRAW)
NASDAQ: CMRAW
· Real-Time Price · USD
0.02
null (null%)
At close: Sep 17, 2024, 10:00 PM
Comera Life Sciences Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 1.77M | 476.3K | 1.54M | 446.61K | 2.67M | 4.94M | 3.86M | 6.51M | 450.56K | -155.43K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 310.85K |
Long-Term Investments | 50K | 50K | 50K | 50K | 50K | 50K | 107.1M | 107.09M | 107.09M | n/a |
Other Long-Term Assets | 43.2K | 43.2K | 43.2K | 43.2K | 43.2K | 43.2K | -107.02M | -107M | n/a | n/a |
Receivables | 100K | 250K | 248.63K | 34.32K | 293.82K | 149K | 148K | 221.55K | n/a | n/a |
Inventory | n/a | 1.04M | 535.1K | 2.51M | 1.27M | 291.81K | 360.44K | 2K | n/a | n/a |
Other Current Assets | 55.95K | 83.86K | 85.05K | 1.67M | 51.49K | 31.26K | n/a | 185.92K | n/a | n/a |
Total Current Assets | 2.63M | 1.82M | 2.41M | 3.06M | 4.29M | 5.41M | 4.38M | 6.78M | 591.45K | 155.43K |
Property-Plant & Equipment | 348.25K | 422.94K | 498.48K | 570.82K | 554.99K | 626.62K | 500.55K | 554.54K | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 441.45K | 516.14K | 591.68K | 664.01K | 648.19K | 719.82K | 582.75K | 636.74K | 107.09M | n/a |
Total Assets | 3.07M | 2.34M | 3M | 3.73M | 4.94M | 6.13M | 4.96M | 7.42M | 107.68M | n/a |
Account Payables | 1.14M | 2.15M | 1.77M | 1.46M | 1.44M | 1.43M | 631.48K | 416.94K | n/a | n/a |
Deferred Revenue | n/a | 36.31K | n/a | 144.28K | n/a | n/a | 47.73K | 498.7K | n/a | n/a |
Short-Term Debt | n/a | 584.81K | n/a | 455.56K | 911.12K | n/a | 124K | n/a | n/a | n/a |
Other Current Liabilities | 1.09M | 347.82K | 452.04K | 2.01M | 411.67K | 663.81K | 224.07K | 356.91K | 1.47K | n/a |
Total Current Liabilities | 2.93M | 3.95M | 3.36M | 5.06M | 3.43M | 2.52M | 1.03M | 1.05M | 1.47K | n/a |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | 169.57K | n/a | n/a | n/a |
Other Long-Term Liabilities | 4.36M | 4.74M | 4.86M | 4.8M | 4.76M | 5.18M | 20.86M | 20.86M | 9.28M | n/a |
Total Long-Term Liabilities | 4.36M | 4.74M | 4.91M | 4.92M | 4.94M | 5.4M | 21.03M | 21.06M | 9.28M | n/a |
Total Liabilities | 7.29M | 8.69M | 8.26M | 9.97M | 8.37M | 7.92M | 22.05M | 22.1M | 9.29M | n/a |
Total Debt | 171.6K | 806.69K | 271.17K | 775.05K | 1.28M | 413.28K | 293.57K | 323.06K | n/a | n/a |
Common Stock | 2.76K | 1.92K | 1.92K | 1.67K | 1.67K | 1.59K | 1.35K | 400.00 | 107.09M | n/a |
Retained Earnings | -40.95M | -38.8M | -37.39M | -34.9M | -31.94M | -28.86M | -19.78M | -16.9M | -8.69M | n/a |
Comprehensive Income | n/a | -4.69B | n/a | -4.52M | n/a | n/a | -20,857.5B | -20.86M | n/a | n/a |
Shareholders Equity | -4.22M | -6.35M | -5.26M | -6.25M | -3.43M | -1.79M | -17.09M | -14.69M | 98.39M | 151.91K |
Total Investments | 50K | 50K | 50K | 50K | 50K | 50K | 107.1M | 107.09M | 107.09M | 310.85K |